Skip to main content

Towards more efficient and accessible personalised medicine in Europe

The PRECISEU project (PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope), funded by the Horizon Europe programme, aims to improve the efficiency of health innovation ecosystems across Europe. It does so by promoting collaboration among regions and key stakeholders such as scientists, entrepreneurs, and innovation networks to accelerate the adoption of personalised medicine and the implementation of disruptive health technologies.

There is a significant gap between leading and emerging innovation regions, with direct impacts on the economy, quality of life, and healthcare equity. PRECISEU was created with the aim of reducing this fragmentation by strengthening connections between regional ecosystems and fostering the exchange of innovative practices and solutions. The project will run for 60 months, allowing for sustained long-term work to ensure real and replicable results.

The main objectives of the project are:

  • To harness the potential of health data to improve treatments and develop personalised solutions by creating a data environment that is accessible and useful for researchers, professionals, and patients.

  • To facilitate the development and access to ATMPs (Advanced Therapy Medicinal Products), enabling patients to benefit more quickly from new therapies.

  • To streamline access to the European market for innovations in personalised medicine, with validation and adoption mechanisms that are efficient within healthcare systems.

  • To establish a common European model for personalised medicine, with shared policies, regulations, and practices among EU member states.
     

Through these actions, PRECISEU will contribute to a more efficient, cohesive, and equitable healthcare system, with the capacity to respond to the specific needs of each region and to advance toward a digital and sustainable transformation of Europe’s health systems.

For more information, contact us at preciseu@biocat.cat.

PRECISEU call for projects in personalised medicine innovation

The European project PRECISEU has launched a call for proposals to support interregional innovation projects in personalised medicine. The aim is to accelerate the market uptake of new solutions in areas such as advanced therapies and the use of health data.

The call is addressed to international consortia and funds projects with an advanced level of maturity and a clear pathway to market.

 

Who can apply?

Companies, research centres, universities, hospitals and other organisations can participate.
To receive funding: the entity must be established in a region with a participating funding agency. In Catalonia: Departament de Salut and ACCIÓ.
 

What are the project requirements?

  • Areas: advanced therapies or health data
  • Level: between TRL 6 and TRL 8
  • With a clear market orientation (including a regulatory pathway)
     

What are the consortium requirements?

  • Minimum 3 independent entities
  • From 3 different funding regions across at least 2 countries
  • Must include at least one SME
  • The coordinator must be based in a funding region
     

What funding is available?

  • Up to €3M per project
  • Up to €600,000 per entity
     

What are the key dates?

  • Application deadline: 14 June 2026 (17:00 CEST)
  • Results: 31 July 2026
  • Project implementation: from October 2026 to March 2029
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.